MRCP+
MRCP+ provides enhanced visualization and quantitative assessment of the biliary tree and pancreatic duct that cannot be obtained via a standard abdominal MRCP or ERCP. Enabling the evaluation of hepatobiliary structures and accurate diagnosis, staging and monitoring disease and treatment response.
The number of strictures measure provided by MRCP+ is the only biomarker under review by the FDA’s Biomarker Qualification Program (BQP) for PSC.
Combining MRCP+ with LiverMultiScan
cT1 provides a comprehensive whole liver slice assessment of fibro-inflammation, enabling non-invasive staging of disease activity and treatment response monitoring across several autoimmune liver conditions.
Case Study
A 22-year old male with PSC/AIH overlap syndrome on prednisolone and azathioprine; responded to treatment.
Combining LiverMultiScan with the quantitative measures provided by MRCP+, enables precise monitoring of bile duct and parenchymal liver health across a range of autoimmune liver diseases in a single, non-contrast MRI scan.
Connect with Our Team
Do you have questions about our clinical or pharmaceutical solutions?
Our team is here to help. Simply share your question and your email address, and a member of the team will get back to you directly.